Literature DB >> 8790884

An antiviral effect of nitric oxide: inhibition of reovirus replication.

T L Pertile1, K Karaca, J M Sharma, M M Walser.   

Abstract

We have previously shown that macrophages from chickens infected with avian reovirus are primed to produce nitric oxide (NO) in response to T cell cytokines and bacterial lipopolysaccharide (LPS). We now show that NO exerts potent antireovirus effects. Reovirus replication was substantially reduced in a chicken macrophage cell line, HD11, induced to make NO by stimulation with LPS or conditioned medium from concanavalin A-stimulated spleen cells. The use of a competitive inhibitor of nitric oxide synthase, NG-monomethyl-L-arginine, reduced the antiviral effect of LPS-stimulated HD11 cells. Cytostatic effects were concurrent with the observed antiviral effects of NO. Among these cytostatic effects were reduction in DNA synthesis, protein synthesis, and mitochondrial metabolism. These results indicated that a potential consequence of macrophage priming following virus infection is the protection of cells against virus-induced replication and cytopathic effects, and this protection may be mediated by the cytostatic effects of NO on the host cell.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8790884

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  14 in total

1.  Endotoxin stimulates liver macrophages to release mediators that inhibit an early step in hepadnavirus replication.

Authors:  U Klöcker; U Schultz; H Schaller; U Protzer
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Reovirus infection of the CNS enhances iNOS expression in areas of virus-induced injury.

Authors:  Robin J Goody; Cristen C Hoyt; Kenneth L Tyler
Journal:  Exp Neurol       Date:  2005-10       Impact factor: 5.330

3.  Nitric oxide and macrophage antiviral extrinsic activity.

Authors:  F Benencia; M C Courreges
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

4.  Infection of primary cultures of human Kupffer cells by Dengue virus: no viral progeny synthesis, but cytokine production is evident.

Authors:  P Marianneau; A M Steffan; C Royer; M T Drouet; D Jaeck; A Kirn; V Deubel
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

5.  The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus.

Authors:  D F Stojdl; N Abraham; S Knowles; R Marius; A Brasey; B D Lichty; E G Brown; N Sonenberg; J C Bell
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

6.  Avian reovirus major mu-class outer capsid protein influences efficiency of productive macrophage infection in a virus strain-specific manner.

Authors:  D O'Hara; M Patrick; D Cepica; K M Coombs; R Duncan
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

7.  Astrovirus-induced synthesis of nitric oxide contributes to virus control during infection.

Authors:  Matthew D Koci; Laura A Kelley; Diane Larsen; Stacey Schultz-Cherry
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

8.  Discovery of mammalian genes that participate in virus infection.

Authors:  Edward L Organ; Jinsong Sheng; H Earl Ruley; Donald H Rubin
Journal:  BMC Cell Biol       Date:  2004-11-02       Impact factor: 4.241

9.  Single stranded (ss)RNA-mediated antiviral response against infectious laryngotracheitis virus infection.

Authors:  Mohamed Sarjoon Abdul-Cader; Upasama De Silva Senapathi; Hanaa Ahmed-Hassan; Shayan Sharif; Mohamed Faizal Abdul-Careem
Journal:  BMC Microbiol       Date:  2019-02-08       Impact factor: 3.605

10.  Infectious bronchitis corona virus establishes productive infection in avian macrophages interfering with selected antimicrobial functions.

Authors:  Aruna Amarasinghe; Mohamed Sarjoon Abdul-Cader; Sadiya Nazir; Upasama De Silva Senapathi; Frank van der Meer; Susan Catherine Cork; Susantha Gomis; Mohamed Faizal Abdul-Careem
Journal:  PLoS One       Date:  2017-08-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.